Pay in 4 interest-free payments of $6.25 Learn more
Ships within 48 hours · Estimated delivery Aug 12 - Aug 17
Some people experience only mild effects while others need extra support from their prescribing team to manage symptoms
The optimistic scenario assumes: Higher weight-loss efficacy, based on emerging data from trials of AOMs Expanded access to the drug, driving higher uptake assumptions Higher persistency, driven by reduced costs and oral forms of the drug and fewer side effects Lower weight regain after stopping the drug Higher non-weight-loss-related mortality impacts The pessimistic scenario, conversely, considers lower efficacy, lower uptake assumptions, higher and quicker weight regain, and lower non-weight-loss-related mortality impacts
We have to rely on claims by the compounds proponents, which is not ideal
The GLP-1 market is only going to grow as the drugs prove useful for a wide array of treatments
US$ 29.62
US$ 28.77
US$ 25.07
US$ 28.52
US$ 28.79
US$ 20.83
